Difficulty swallowing capsules or requirement for a feeding tube.
Patient must be capable of swallowing the ruxolitinib capsules (tablets)
Willing and able to participate in all required evaluations and procedures in this study protocol including swallowing capsules without difficulty
Previous history of difficulty swallowing capsules.
Relapsed/refractory MCL: Willing and able to participate in all study related procedures and therapy including swallowing capsules without difficulty
Newly diagnosed MCL: Willing and able to participate in all study related procedures and therapy including swallowing capsules without difficulty
Willing and able to participate in all required evaluations and procedures in this study protocol including swallowing capsules without difficulty
Willing and able to participate in all study related procedures and therapy including swallowing capsules without difficulty.
Willing and able to participate in all required evaluations and procedures in this study protocol including swallowing capsules without difficulty.
Difficulty swallowing capsules.
All subjects must be capable of swallowing multiple capsules
Willing and able to participate in all study related procedures and therapy including swallowing capsules without difficulty
Patient is capable of swallowing study drug capsules whole.
Willing and able to participate in all study related procedures and therapy including swallowing capsules without difficulty
Willing and able to participate in all required evaluations and procedures in this study protocol including swallowing capsules without difficulty.
Willing and able to participate in all required evaluations and procedures in this study protocol including swallowing capsules without difficulty
Capable of swallowing intact study medication capsules
